Saad Mark E (CIK 1295913) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-10). Recent activity: Buy AXSM (1,429 shares), Buy AXSM (6,231 shares), Sell AXSM (6,231 shares), Buy AXSM (31,346 shares), Sell AXSM (31,346 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-10 | Axsome Therapeutics, Inc. (AXSM) | Director | Buy | 1,429 | $0 |
| 2026-01-02 | Axsome Therapeutics, Inc. (AXSM) | Director | Buy | 6,231 | $49,973 |
| 2026-01-02 | Axsome Therapeutics, Inc. (AXSM) | Director | Sell | 6,231 | $1.0M |
| 2026-01-02 | Axsome Therapeutics, Inc. (AXSM) | Director | Buy | 31,346 | $155,163 |
| 2026-01-02 | Axsome Therapeutics, Inc. (AXSM) | Director | Sell | 31,346 | $5.2M |
| 2025-09-05 | Axsome Therapeutics, Inc. (AXSM) | Director | Buy | 9,127 | $82,143 |
| 2025-09-05 | Axsome Therapeutics, Inc. (AXSM) | Director | Sell | 9,127 | $1.1M |
Source: SEC Form 4 filings · as of 2026-06-10